why choose us

First received: February 06, 2023

Clinical Trial: An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II

Study Status: Completed

Recruit Status: RECRUITING

Condition: Leukocyte Adhesion Deficiency

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Open-Label, Extension Study to Assess the Long-term Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II (LAD II)

Brief Summary: The primary objective of this extension study is to assess the long-term safety and efficacy of AVTX-803 in subjects with LAD II (SLC35C1-CDG).

Read more